Cargando…
Emerging Therapies for the Myelodysplastic Syndromes
Despite considerable advances in our understanding of the molecular and epigenetic underpinnings of the myelodysplastic syndromes (MDS), this diverse group of myeloid neoplasms remains a significant clinical challenge. Considerable barriers to timely development of effective therapy include the dive...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Atlantis Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432342/ https://www.ncbi.nlm.nih.gov/pubmed/34595438 http://dx.doi.org/10.2991/chi.d.191202.001 |